Avalo Therapeutics, Inc. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerecor Inc. (CERC)
CIK: 0001534120
Period of Report: 2020-12-31

Reporting Person: Miller Joseph M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-31	Stock Option (Right to Buy)	$2.64	A	5472	Acquired	2030-12-31	Common Stock (5472)	Direct

Footnotes

F1: 100% of this stock option will immediately vest on the date that it is granted.